Journey101 Home PageArticles


HomeSite MapMail




TESTING TREATMENTS

TESTING TREATMENTS - BETTER RESEARCH
FOR BETTER HEALTHCARE


By Imogen Evans, Hazel Thornton, and Iain Chalmers


REFERENCES 31 - 60
31 Thornton H. The screening debates: time for a broader approach? European Journal of
Cancer 2003;39:1807–9.

32 Adapted from Wilson JMG, Jungner G. Principles and practice of screening for
disease. Public health paper no 34. Geneva: World Health Organisation, 1968.

33 Gray JAM. Evidence-based healthcare. Edinburgh: Churchill Livingstone, 1997.

34 Morris JK. Screening for neuroblastoma in children. Journal of Medical Screening
2002;9:56.

35 Welch HG. Should I be tested for cancer? Maybe not and here’s why. Berkeley and Los
Angeles: University of California Press, 2004. p77.

36 Morris JK. Screening for neuroblastoma in children. Journal of Medical Screening 2002;9:56.

37 Hummel S, Paisley S, Morgan A, et al. Clinical and cost-effectiveness of new and
emerging technologies for early localised prostate cancer: a systematic review.
Health Technology Assessment Report 2003; volume 7, no. 33.

38 Law M. Screening without evidence of efficacy. British Medical Journal 2004;328:301–2.

39 Yamey G, Wilkes M. The PSA storm. British Medical Journal 2002;324:431.

40 Wallis C. Atypical cystic fibrosis – diagnostic and management dilemmas. Journal of
the Royal Society of Medicine 2003;96(suppl 43):2–10.

41 David TJ. Newborn screening for cystic fibrosis. Journal of the Royal Society of Medicine
2004;97: 209–10.

42 Farrell MH, Farrell PM. Newborn screening for cystic fibrosis: ensuring more good
than harm. Journal of Pediatrics 2003;143:707–12.

43 NICE. Guidance on the removal of wisdom teeth, 2000. Available from:
www.nice.org.uk/page.aspx?o=526 [accessed 4 December 2005].

44 Allen C, Glasziou P, Del Mar C. Bed rest: a potentially harmful treatment needing
more careful evaluation. Lancet 1999;354:1229–33.

45 Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analysis of randomized control trials and recommendations of clinical experts. Journal of the American Medical Association 1992;268:240–8.

46 Asher R. Talking sense (Lettsonian lecture, 16 Feb, 1959). Transactions of the Medical Society of London, vol LXXV, 1958–59. Reproduced in: Jones, FA, ed. Richard Asher talking sense. London: Pitman Medical, 1972.

47 Noseworthy JH, Ebers GC, Vandervoort MK, et al. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology 1994;44:16–20.

48 Antiplatelet Trialists’ Collaborative Group. Collaborative overview of randomised trials of antiplatelet therapy. British Medical Journal 1994;308:81–106.

49 Beral V, for the Million Women Study Collaborators. Breast cancer and hormonereplacement therapy in the Million Women Study. Lancet 2003;362:419–27.

50 Address by the Rt. Hon. Lord Rayleigh. In: Report of the fifty-fourth meeting of the British Association for the Advancement of Science; held at Montreal in August and September 1884, London: John Murray, pp3–23.

51 Reynolds LA, Tansey EM, eds. Prenatal corticosteroids for reducing morbidity and mortality after preterm birth. London: Wellcome Trust Centre for the History of Medicine, 2005.

52 Lindley RI. Personal communication, 2005.

53 Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. New England Journal of Medicine 2001;344:1031–7.

54 Loudon I. The use of historical controls and concurrent controls to assess the effects of sulphonamides, 1936–1945. Available from: www.jameslindlibrary.org [accessed 3 January 2006].

55 Transurethral resection of the prostate for benign prostatic hyperplasia. In: Wennburg JE, McAndrew Cooper M, eds. The Dartmouth Atlas of Healthcare in the United States. Hanover, New Hampshire: Center for Evaluative Clinical Sciences, Dartmouth Medical School, 1996, p142. The 1996 edition and the updated 1999 edition are available from: www.dartmouthatlas.org/atlases/atlas_series.shtm [accessed 29 December 2005].

56 Burton MJ, Towler B, Glasziou P. Tonsillectomy versus non-surgical treatment for
chronic/recurrent acute tonsillitis. The Cochrane Database of Systematic Reviews 1999,
Issue 3. Art. No.: CD001802. Available from: www.thecochranelibrary.com
[accessed 3 January 2006].

57 Ashcroft R. Giving medicine a fair trial. British Medical Journal 2000;320:1686.

58 Smithells RW. Iatrogenic hazards and their effects. Postgraduate Medical Journal
1975;15:39–52.

59 General Medical Council. Seeking patients’ consent: the ethical considerations. November 1998. Available from: www.gmc-uk.org/guidance/library/consent.asp [accessed 6 December 2005].

60 Chalmers I, Lindley R. Double standards on informed consent to treatment. In: Doyal L, Tobias JS, eds. Informed consent in medical research. London: BMJ Books 2001, pp266–75.


HOME   BLOG   NEWSLETTER   SIGN UP   PRIVACY   SITE MAP   OTHER INFO   CONTACT US

Designed and Powered by RomWell.net
>